Announcements Trials
Browse Landscape

Phase

Phase 1 4Phase 1/2 2

Status

Recruiting 6Unknown 2Completed 2

Sponsor Class

INDUSTRY 6OTHER 3

Study Type

Interventional 6

Sponsor

Cancer Type

Thoracic 6

Conditions

Carcinoma, Non-Small-Cell Lung 429Breast Neoplasms 298Neoplasms 296Colorectal Neoplasms 242Neoplasm Metastasis 197Ovarian Neoplasms 171Lung Neoplasms 150Recurrence 147Prostatic Neoplasms 146Pancreatic Neoplasms 142Multiple Myeloma 136Stomach Neoplasms 129Squamous Cell Carcinoma of Head and Neck 128Melanoma 123Leukemia, Myeloid, Acute 115Endometrial Neoplasms 115Advanced Solid Tumors 113Advanced Solid Tumor 108Carcinoma, Hepatocellular 102Triple Negative Breast Neoplasms 101Small Cell Lung Carcinoma 88Uterine Cervical Neoplasms 86Lymphoma, Non-Hodgkin 83Carcinoma, Renal Cell 72Lymphoma, Follicular 71Lymphoma 67Leukemia, Lymphocytic, Chronic, B-Cell 65Solid Tumor 64Lymphoma, Large B-Cell, Diffuse 64Hematologic Neoplasms 62

Interventions

Injections 2aflutinib 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Recruiting × INDUSTRY × Advanced Lung Cancer × Clear all
NCT07367529 2026-05-05

A Clinical Trial on the Efficacy and Safety of TQB6411 for Injection

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 1/2 Recruiting
465 enrolled
Thoracic

Advanced Lung Cancer

NCT07229599 2025-11-17

A Study of MHB036C Combined With Anti-tumor Therapies in Patients With Advanced Lung Cancer

Minghui Pharmaceutical (Hangzhou) Ltd

Phase 1/2 Recruiting
300 enrolled
Thoracic

Advanced Lung Cancer

NCT06945523 2025-06-04

Clinical Study on Chimeric Antigen Receptor T Lymphocyte (CAR-T) Targeting CEA for the Treatment of CEA - Positive Advanced Lung Cancer

Chongqing Precision Biotech Co., Ltd

Phase 1 Recruiting
60 enrolled
Thoracic

Advanced Lung Cancer

NCT06992583 2025-05-28

Targeted Anti-CEA CAR-T Immunotherapy for Advanced Lung Cancer

Chongqing Precision Biotech Co., Ltd

Phase 1 Recruiting
60 enrolled
Thoracic

Advanced Lung Cancer

NCT06903117 2025-04-03

Anti-CEA CAR-T for Advanced CEA-Positive Lung Carcinoma

Chongqing Precision Biotech Co., Ltd

Phase 1 Recruiting
60 enrolled
Thoracic

Advanced Lung Cancer

NCT06768151 2025-01-10

A Clinical Trial of CEA Targeting CAR-T for CEA Positive Advanced Lung Cancer

Chongqing Precision Biotech Co., Ltd

Phase 1 Recruiting
48 enrolled
Thoracic

Advanced Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡